| Comprehensive genomic characterization defines human glioblastoma genes and core pathways Cancer Genome Atlas Research Network Tissue source sites: Duke University ... Nature 455 (7216), 1061-1068, 2008 | 7319 | 2008 |
| The somatic genomic landscape of glioblastoma CW Brennan, RGW Verhaak, A McKenna, B Campos, H Noushmehr, ... cell 155 (2), 462-477, 2013 | 4916 | 2013 |
| Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers PA Steck, MA Pershouse, SA Jasser, WKA Yung, H Lin, AH Ligon, ... Nature genetics 15 (4), 356-362, 1997 | 4124 | 1997 |
| Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma HS Friedman, MD Prados, PY Wen, T Mikkelsen, D Schiff, LE Abrey, ... Journal of clinical oncology 27 (28), 4733-4740, 2009 | 2922 | 2009 |
| Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma M Ceccarelli, FP Barthel, TM Malta, TS Sabedot, SR Salama, BA Murray, ... Cell 164 (3), 550-563, 2016 | 1980 | 2016 |
| Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials ET Wong, KR Hess, MJ Gleason, KA Jaeckle, AP Kyritsis, MD Prados, ... Journal of Clinical Oncology 17 (8), 2572-2572, 1999 | 1074 | 1999 |
| A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo J Fueyo, C Gomez-Manzano, R Alemany, PSY Lee, TJ McDonnell, ... Oncogene 19 (1), 2-12, 2000 | 978 | 2000 |
| Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse WKA Yung, MD Prados, R Yaya-Tur, SS Rosenfeld, M Brada, ... Journal of Clinical Oncology 17 (9), 2762-2771, 1999 | 925 | 1999 |
| PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis W Yang, Y Xia, D Hawke, X Li, J Liang, D Xing, K Aldape, T Hunter, ... Cell 150 (4), 685-696, 2012 | 798 | 2012 |
| MMAC1/PTEN Mutations in Primary Tumor Specimens and Tumor Cell Lines DHF Teng, R Hu, H Lin, T Davis, D Iliev, C Frye, B Swedlund, KL Hansen, ... Cancer research 57 (23), 5221-5225, 1997 | 667 | 1997 |
| FoxM1 promotes β-catenin nuclear localization and controls Wnt target-gene expression and glioma tumorigenesis N Zhang, P Wei, A Gong, WT Chiu, HT Lee, H Colman, H Huang, J Xue, ... Cancer cell 20 (4), 427-442, 2011 | 623 | 2011 |
| Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas HA Fine, WD Figg, K Jaeckle, PY Wen, AP Kyritsis, JS Loeffler, VA Levin, ... Journal of Clinical Oncology 18 (4), 708-708, 2000 | 588 | 2000 |
| Phase I study of DNX-2401 (Delta-24-RGD) oncolytic adenovirus: replication and immunotherapeutic effects in recurrent malignant glioma FF Lang, C Conrad, C Gomez-Manzano, WKA Yung, R Sawaya, ... Journal of clinical oncology 36 (14), 1419, 2018 | 577 | 2018 |
| Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08 PY Wen, WKA Yung, KR Lamborn, PL Dahia, Y Wang, B Peng, LE Abrey, ... Clinical Cancer Research 12 (16), 4899-4907, 2006 | 502 | 2006 |
| Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results FF Lang, JM Bruner, GN Fuller, K Aldape, MD Prados, S Chang, ... Journal of Clinical Oncology 21 (13), 2508-2518, 2003 | 482 | 2003 |
| Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas KR Lamborn, WKA Yung, SM Chang, PY Wen, TF Cloughesy, ... Neuro-oncology 10 (2), 162-170, 2008 | 460 | 2008 |
| Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis T Sano, H Lin, X Chen, LA Langford, D Koul, ML Bondy, KR Hess, ... Cancer research 59 (8), 1820-1824, 1999 | 438 | 1999 |
| Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN MA Davies, D Koul, H Dhesi, R Berman, TJ McDonnell, D McConkey, ... Cancer research 59 (11), 2551-2556, 1999 | 404 | 1999 |
| Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway J Fueyo, R Alemany, C Gomez-Manzano, GN Fuller, A Khan, CA Conrad, ... Journal of the National Cancer Institute 95 (9), 652-660, 2003 | 395 | 2003 |
| Longitudinal molecular trajectories of diffuse glioma in adults FP Barthel, KC Johnson, FS Varn, AD Moskalik, G Tanner, E Kocakavuk, ... Nature 576 (7785), 112-120, 2019 | 390 | 2019 |
